ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,557.18
0.36%
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs Yen
154.995
0.16%
Brent Oil
82.725
-0.17%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cardiff Oncology Inc (CRDF)

  7. Cardiff Oncology Inc (CRDF) ニュース

CRDF

Cardiff Oncology (CRDF)

Cardiff Oncology Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CRDF
日付受信時刻ニュースソース見出しコード企業名
2024/05/0305 : 05GlobeNewswire Inc.Cardiff Oncology Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2024/04/2605 : 05GlobeNewswire Inc.Cardiff Oncology to Report First Quarter 2024 Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2024/04/0905 : 05GlobeNewswire Inc.Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical StudyNASDAQ:CRDFCardiff Oncology Inc
2024/03/0808 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
2024/03/0808 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
2024/03/0808 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
2024/03/0808 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
2024/03/0706 : 05GlobeNewswire Inc.Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024NASDAQ:CRDFCardiff Oncology Inc
2024/03/0106 : 07GlobeNewswire Inc.Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2024/03/0106 : 06GlobeNewswire Inc.Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRCNASDAQ:CRDFCardiff Oncology Inc
2024/03/0106 : 05GlobeNewswire Inc.Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)NASDAQ:CRDFCardiff Oncology Inc
2024/03/0106 : 00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRDFCardiff Oncology Inc
2024/02/2622 : 00GlobeNewswire Inc.Cardiff Oncology to Present at the Cowen 44th Annual Health Care ConferenceNASDAQ:CRDFCardiff Oncology Inc
2024/02/2222 : 00GlobeNewswire Inc.Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2024/02/0706 : 01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRDFCardiff Oncology Inc
2024/01/1800 : 30PR Newswire (US)Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer ResearchNASDAQ:CRDFCardiff Oncology Inc
2024/01/0823 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
2023/11/2106 : 05PR Newswire (US)Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:CRDFCardiff Oncology Inc
2023/11/0305 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
2023/11/0305 : 05PR Newswire (US)Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2023/11/0305 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRDFCardiff Oncology Inc
2023/10/2705 : 05PR Newswire (US)Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2023/09/2705 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
2023/09/2705 : 05PR Newswire (US)Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib MonotherapyNASDAQ:CRDFCardiff Oncology Inc
2023/09/0521 : 00PR Newswire (US)Cardiff Oncology to Present at Upcoming Investor Conferences in SeptemberNASDAQ:CRDFCardiff Oncology Inc
2023/08/1005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
2023/08/1005 : 05PR Newswire (US)Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
2023/08/1005 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRDFCardiff Oncology Inc
2023/08/0805 : 42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
2023/08/0805 : 05PR Newswire (US)Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer RelationshipNASDAQ:CRDFCardiff Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CRDF

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
FX
USDGBP
US Dollar vs Sterling
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
CCOM
US100
US Tech 100
NYSE
KO
Coca Cola
AMEX
XLE
Energy Select Sector SPDR
FX
USDJPY
US Dollar vs Yen
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有